Stemcell101.com
  • Home
  • About Us
    • About Us
    • Causes We Support
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
Select Page

Symptomless liver condition linked to heart and kidney disease

by rss feed | Sep 10, 2026 | News Feeds

A common liver condition thought to be harmless could be dramatically increasing the risk of heart disease, kidney failure and premature death, according to a new review led by University of Manchester and Northern Care Alliance NHS Foundation Trust researchers. Read...

Compassion and connection at heart of suicide prevention

by rss feed | Sep 10, 2026 | News Feeds

Compassion, trust and person-centerd care must be at the heart of supporting people experiencing suicidal distress, according to a leading Adelaide University suicide prevention expert. Read Original...

Evaluating new approaches for rare disease research

by rss feed | Sep 10, 2026 | News Feeds

Marcel Nelen discusses his team’s early evaluation of a new workflow for rare disease genomics. Read Original...

Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis

by rss feed | Sep 10, 2026 | News Feeds

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at...

Nighttime light exposure may alter heart structure and function

by rss feed | Sep 10, 2026 | News Feeds

Exposure to light during the nighttime is linked to important and potentially harmful changes to the structure and function of the heart, according to a study of more than 11,000 people published in the European Heart Journal today (Thursday). Read Original...

Tizanidine looked promising early in a migraine trial, but the benefit did not last

by rss feed | Sep 10, 2026 | News Feeds

A randomized, double-blind, placebo-controlled trial found that low-dose tizanidine did not provide sustained reductions in headache burden over 12 weeks in people with episodic migraine, despite a transient improvement with the 1 mg dose at week 4. Exploratory...
« Older Entries
Next Entries »

Quick Navigation

  • Home
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
  • About Us
    • About Us
    • Causes We Support

RSS Recent Post

Sign up for StemCell101.com Mailing List

By subscribing to our mailing list, you will get the latest news from us.